Rectal Cancer Clinical Trial
— RAVALOfficial title:
Radiographic Validation of the Inferior Mesenteric Artery Tie Level in Rectal Cancer Surgery
NCT number | NCT03875612 |
Other study ID # | UmU-RAVAL |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 12, 2016 |
Est. completion date | August 31, 2019 |
Verified date | September 2019 |
Source | Umeå University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The inferior mesenteric artery is the feeding vessel for tumours in the rectum. When
performing surgery for these tumours, the surgeon can cut the vessel close to the aorta or
after the vessel bifurcates to the superior rectal artery and the left colic artery. A close
division is termed a high tie (and the other, a low tie) and might entail a better lymph node
extraction, possibly removing metastasis, but can also lead to nerve damage and e.g. bowel
dysfunction.
There is no clear evidence favouring either tie level, and large amounts of data are needed
to establish superiority as any effects is likely to be small. One such method is to use
national registries with prospectively collected data on e.g. level of tie and cancer
relapse. However, it is not always easy to determine the level of tie while in the operating
room and registries might also contain erroneous data.
In order to determine the validity of such data, comparisons to objective measures are
needed. This study is an attempt to correlate radiographic imaging to the suggested tie
level, as indicated by the surgeon in the operative report and by the nationwide Swedish
Colorectal Cancer Registry. If the registry variable tie level has a high correlation with
imagining, researchers can more reliably use the registry to establish the benefits and
drawbacks with high tie in rectal cancer surgery.
Status | Completed |
Enrollment | 98 |
Est. completion date | August 31, 2019 |
Est. primary completion date | August 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years and older |
Eligibility |
Inclusion Criteria: - Operated for primary rectal cancer - 1-year radiological follow-up is planned - Ability to leave informed consent Exclusion Criteria: - Contrast medium insensitivity - Diagnosis of renal failure - Age below 40 years - Thyroid disease for which radioactive iodine treatment might be considered |
Country | Name | City | State |
---|---|---|---|
Sweden | Peter Matthiessen | Örebro | |
Sweden | Umeå University Hospital | Umeå |
Lead Sponsor | Collaborator |
---|---|
Umeå University | Örebro University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensitivity of registered level of tie | Sensitivity of level of tie in the Swedish Colorectal Cancer Registry, using radiological determination with computerized tomography as reference. | 1 year postoperatively | |
Primary | Specificity of registered level of tie | Specificity of level of tie in the Swedish Colorectal Cancer Registry, using radiological determination with computerized tomography as reference. | 1 year postoperatively | |
Secondary | Artery stump length in low tie surgery | Stump length of the ligated inferior mesenteric artery in low tie surgery. | 1 year postoperatively | |
Secondary | Lymph node yield in relation to level of tie and artery stump length | Number of lymph nodes from histopathology, stratified by level of radiological tie and correlated to stump length. | 1 year postoperatively | |
Secondary | Cancer recurrence by tie level | Any rectal cancer recurrence stratified by level of radiological tie | 5 years postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A |